A Leader in Clinical Research
Clinical Trials at UMDNJ

FEATURES

Aging
Confronting Alzheimer’s • Decoding Dementias • Parkinson’s, Anxiety and Depression • Exercising the Aging Brain • Moving Forward • Nursing Research Fosters Independence

Pediatrics
Where Kids Volunteer • The Doctor’s Orders: A Cure • More Options for Kids’ Psychiatric Problems • Autism Therapies on Trial

Inflammation
Diagnosis: Scleroderma • Beyond the Standard of Care • The Old Exercise Remedy • For Her Patients’ Sake

Cancer
Staying Alive • New Trials to Beat Cancer • Recruiting Minorities for Cancer Trials • Adding Years With Experimental Therapies • Promising Medicines to Try • Trials for Gastrointestinal Malignancies

Dentistry
Smiling Once Again • The Puzzle of Burning Mouth Syndrome • Down in the Mouth

Women’s Health
Targeting Women’s Cancers • Putting Women First • Help for Headaches • Bringing Basic Science to the Clinic • Sleep and Fibromyalgia Symptoms

Cardiology
Protecting the Heart [and the Brain] • 911: Endangered Heart

Environment
On the Road Again • What’s in the Paint? • Treating Tobacco Dependency and Mental Illness • Kids and Their Environments: a Landmark Study • The Cancer/Clock Connection

Infection
Healthy Volunteers: The Inside Scoop • HIV Has A Female Face • Liver Disease: de la Torre's Dilemma • TB Trials: Secrets to Success

Community
Man with a Mission • Numbers Count  • Battling TB Here and Abroad • Breaking Down Barriers to Cancer Care • Her Happy Ending for HIV Pregnancy • Triggering Change in Transfusion Medicine

Endpage
Five Questions with Paula Bistak

Your comments and letters are welcome. Please send them to:

umdnjeditor@umdnj.edu

UMDNJ-University Marketing Communications
Unversity Heights
65 Bergen Street
P.O. Box 1709, Suite 1328
Newark, NJ 07101-1709

 

Left: Kathleen W. Scotto, PhD, Vice President of Research. Right: Judith Ladd, PhD, Interim Director, Clinical Research Organization

UMDNJ – A Leader in Clinical Research

T
print this
Share this:

he Office of Research at UMDNJ is embarking on an exciting venture. With hundreds of University investigators conducting hundreds of
current clinical trials, we are setting the foundation for our Clinical Research Organization (CRO).

What will our CRO offer? We’ll give greater support to the
pharmaceutical industry in determining the safety and efficacy of new drugs and help to bring the drugs to market more quickly and efficiently. We’ll offer a high level of proficiency in managing all phases of clinical trials, including: trial design; clinical, medical and safety monitoring; clinical laboratory services; data management and analysis; recruitment of participants; preparation of applications for FDA approval; and regulatory affairs and budgets. Also, our academic specialists have longstanding, trusting relationships with patients seeking optimum care, which often includes participation in clinical research.

CROs have proven their worth worldwide. In the U.S., there are CROs at Harvard, Johns Hopkins, the Cleveland Clinic, the University of Alabama, Birmingham, the University of Kentucky, to name just a few. The process of creating a CRO is important for UMDNJ as it establishes its leadership role in clinical research in NJ and the region. In fact, President Owen has identified building the CRO as one of the University’s top priorities.

UMDNJ is conducting sophisticated clinical research in many specialty areas throughout New Jersey. This issue of UMDNJ Magazine serves as an introduction to the work of some of our experts in cancer, aging, women’s health, environmental
medicine, cardiology, pediatrics, dentistry, and inflammatory and infectious diseases. Visit our Website during the upcoming months as we coordinate and enhance our clinical research capabilities to provide a single point of contact for organizations exploring the possibility of sponsoring clinical research at UMDNJ.

Sincerely,

Kathleen W. Scotto, PhD
Vice President of Research

Judith Ladd
Interim Director, Clinical Research Organization